Acute Gout Management

First-Line Treatment Options

The American College of Rheumatology recommends initiating treatment with NSAIDs, colchicine, or corticosteroids as first-line monotherapy within 24 hours of symptom onset, with corticosteroids preferred in patients with renal disease, heart failure, or cardiovascular disease due to superior safety profile 1, 2, 3
The European League Against Rheumatism suggests that all three first-line agents are equally effective for acute gout when initiated early, but selection depends on patient-specific contraindications 1, 2
NSAIDs should be used at full FDA-approved anti-inflammatory doses until the gouty attack completely resolves, with options including naproxen 500mg twice daily, indomethacin, and sulindac 1, 4
Colchicine is most effective when started within 36 hours of symptom onset, with a dosing regimen of 1.2mg at first sign of flare, followed by 0.6mg one hour later (maximum 1.8mg over one hour) 1, 3, 4
Corticosteroids are the preferred first-line option in patients with renal disease, heart failure, cirrhosis, cardiovascular disease, or elderly patients, with a recommended regimen of prednisolone 30-35mg daily for 3-5 days 2, 3

For mild to moderate pain (≤6/10) with limited joint involvement (1-3 small joints or 1-2 large joints), monotherapy with any first-line agent is appropriate, with selection based on patient comorbidities and contraindications 1, 2, 3
For severe pain (≥7/10) or polyarticular involvement (≥4 joints), combination therapy is recommended, with effective combinations including colchicine + NSAIDs, oral corticosteroids + colchicine, or intra-articular steroids with any other modality 2, 3

Treatment must be initiated within 24 hours of symptom onset for optimal efficacy, and should be continued at full dose until the gouty attack has completely resolved 1, 2, 3, 4
Existing urate-lowering therapy should not be stopped during an acute attack, and new urate-lowering therapy should not be initiated during an acute attack 1, 2, 3

Inadequate response is defined as <20% improvement in pain within 24 hours or <50% improvement after 24 hours, and should be managed by switching to another monotherapy or adding a second recommended agent 1, 2

Low-dose colchicine 0.5-1mg daily is first-line prophylaxis when starting any urate-lowering therapy, with alternatives including low-dose NSAIDs or low-dose prednisone if colchicine is not tolerated or contraindicated 1, 3

Indomethacin should not be preferentially used due to its potential for more adverse effects without efficacy advantage over other NSAIDs 3
High-dose colchicine regimens should not be used due to increased toxicity without improved efficacy 3
Treatment should not be delayed waiting for definitive diagnosis, as early treatment within 24 hours is more important 3